PubMed Health⌕ Search

PubMed · 1791885

Immunoregulation in man.

Abstract

The process during which a B lymphocyte, after ligation of the antigen receptor, differentiates into a high-rate antibody-secreting plasma cell is under strict regulatory control of T lymphocytes and their soluble products. For most so-called T-cell-dependent (protein) antigens, antigen-specific CD4-positive T cells or T-cell factors participate in the transition of resting into activated B cell. Terminal B-cell differentiation, including immunoglobulin class switch, is regulated by a variety of (antigen non-specific) cytokines which act in a highly coordinated fashion. The other major class of naturally occurring antigens, the so-called T-cell independent (polysaccharide) antigens, apparently can induce B-cell activation in the absence of antigen-specific CD4-positive T cells. Terminal B-cell differentiation, however, also depends on the action of cytokines, although the relative contribution of individual cytokines remains to be determined. Downregulation of both T-cell-dependent and T-cell independent antigens is mediated by specific suppressor T cells. Next to this "internal control" by regulatory T cells, it is important to realize that components of the (neuro-)endocrine system (such as the endorphins and the family of insulin-like growth factors) and the complement system also exert important immunoregulatory functions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G T Rijkers, B J Zegers. 1991. Immunoregulation in man.. https://pubmed.ncbi.nlm.nih.gov/1791885/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Cellular mechanisms implicated in anti-erythrocyte alloimmunization].

In many clinical situations patients are dependent on blood transfusions. Occurrence of alloimmunization to blood group antigens (BGA) complicates the transfusion strategy and may be involved in clinical transfusion stalemate situations. B cell differentiation into antibody-secreting plasma cells is triggered by antigen and requires helper T cells which produce cytokines. Although antibodies implicated in BGA alloimmunization have been studied for many years, little is known about helper T cell responses that drive their production. Few studies on BGA specific T cell responses have been published today. This review summarizes the new developments in the field of cellular mechanisms implicated into antibody production. The definition of immunodominant peptides derived from RhD and Jk(a) BGAs, the cytokine patterns induced and the HLA class II molecules implicated in their presentation are analyzed. A tolerogenic route for RhD immunodominant peptides is experimented. Identification of such immunodominant peptides, the cytokine patterns induced and the HLA class II molecules implicated in their presentation, would facilitate the design of new therapeutic strategies including the specific control of alloimmunization with peptide antigen tolerogens or the ex-vivo induction of regulatory T cells.

Antigens, T-Independent↗

Differentially expressed genes in association with in vitro invasiveness of human epithelioid sarcoma.

AIMS: Differential display reverse transcription polymerase chain reaction (RT-PCR) was performed to identify genes associated with the invasive potential of human epithelioid sarcoma. METHODS: Two different clonal subpopulations, GRU-1A and GRU-1B, derived from the same human epithelioid sarcoma cell line GRU-1 and known to differ greatly in their invasive potential were compared by means of mRNA fingerprinting. RESULTS: Using a set of 10 arbitrary upstream primers and nine anchored oligo-dT primers, 22 candidate gene fragments were identified; differential expression was confirmed in four of these fragments by northern blot analysis. At the mRNA level, apoferritin light chain was predominantly expressed by the highly invasive cell line GRU-1A. In contrast, the mitochondrial gene M1, encoding cytochrome c oxidase I, and the TI-227H gene were expressed more strongly by the low invasive cell line GRU-1B. Furthermore, a novel gene fragment was identified and cloned that was preferentially expressed in the low invasive cell line GRU-1B, and therefore might have an inhibitory role in invasion. Consequently, this gene fragment was designated as expressed in low invasive sarcoma cells (ELISC-1). CONCLUSIONS: A novel gene fragment (ELISC-1) and three known genes were identified as potential regulators of tumour invasiveness. Cloning of the entire sequence of ELISC-1 and subsequent investigations are required to establish its biological role.

Antigens, T-Independent↗